In the high-stakes race to develop the next life-saving therapy, one crucial player is often overlooked—but without it, innovation would grind to a halt. The investigational new drug CDMO industry is the backbone of pharmaceutical R&D, quietly supporting biotech firms and pharma giants as they navigate the complex path from discovery to human trials These specialized contract...